Childhood Kidney Diseases reviews all received materials. All papers are evaluated by a double-blind, peer-review process. Manuscripts are sent to the two (or more) most relevant investigators, who review the content. The acceptance criteria for all papers are based on the quality and originality of the research and its clinical and scientific significance. An initial decision will normally be made within 2 weeks after the reviewers agree to review a manuscript, and the reviewers’ comments will then be sent to the corresponding authors. Revised manuscripts must be submitted online by the corresponding author. Failure to resubmit the revised manuscript within 4 weeks of the editorial decision is regarded as a withdrawal. The editorial office should be notified if additional time is needed or if an author chooses not to submit a revision. The editorial committee makes decisions concerning editing, revision, and acceptance or rejection, and editing may include shortening an article, reducing the number of illustrations or tables, or changing the paper's format or the order of the manuscript. The editor selects referees, and the results of reviews will be classified as follows:

• • Accepted: The manuscript will be forwarded to the publisher without further corrections.
• • Minor revisions: The author should address the comments from the reviewers, which will be confirmed by the reviewers before being sent to the publisher.
• • Major revisions: The author should address the comments from the reviewers and make the appropriate corrections for review by the three reviewers.
• • Rejection: When one out of the two (or more) reviewers rejects the manuscript, the final decision is made by the editorial committee.
• • Consultation: Review of the manuscript will be done through consultation to subcommittees and subspecialties.

The review and the publication process follow the flow chart below.